Clinical trials recruiting in Yangjiang, China

Phase breakdown

Conditions recruiting in Yangjiang, China

Recruiting trials in Yangjiang, China

• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
  NCT04974138 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
  NCT04974151 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Yangjiang, China?

3 recruiting trials have at least one study site in Yangjiang, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.